Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Stomach drug may tame blood sugar swings in type 1 diabetes

NCT ID NCT06695962

First seen Feb 28, 2026 · Last updated May 23, 2026 · Updated 9 times

Summary

This study tests whether domperidone, a drug that speeds up stomach emptying, can help adults with type 1 diabetes keep their blood sugar in a healthy range. About 70 participants with slow stomach emptying but no digestive symptoms will take either domperidone or a placebo for 28 days. The main goal is to see if the drug increases the time their blood sugar stays between 70 and 180 mg/dL, measured by a continuous glucose monitor.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETIC are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CH Dieppe

    Dieppe, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Amiens

    Amiens, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU de CAEN

    Caen, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU de ROUEN

    Rouen, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Centre Hospitalier Intercommunal Elbeuf, Louviers, Val de Reuil

    Elbeuf, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • GH Le Havre

    Le Havre, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.